Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Melanoma/Skin Cancer
In patients with Von Willebrand disease, who are presenting with cT1N0 SCC of the skin, what dose/fractionation is recommended?
Is there any toxicity/healing issues concerns?
Related Questions
For merkel cell carcinoma of the eyelid, how do you approach post-operative management and what are the recommended radiation treatment volumes?
What is your preferred skin surface maximum dose constraint for skin brachytherapy?
How would you approach a recurrent, cutaneous SCC of the face with high-risk features s/p resection?
What electron beam dose/fractionation would you use for a recurrence basal cell carcinoma of the scalp adjacent to a split thickness skin graft?
In patients with skin squamous cell carcinoma invading the skull, what dose do you limit the brain when treating definitively with radiation?
How do you approach an elderly patient (~80 years) with stage IIC melanoma post resection with oligometastatic brain lesion post intracranial resection which developed 2 years after treatment?
What radiation dose-fractionation regimen would you choose for squamous cell carcinoma of the great toe in a patient who declines surgery?
How would you treat a periungual squamous cell carcinoma of the thumb?
What dose constraint for nasal cartilage would you respect while treating with 6MeV electrons in patients who have a nearby prior radiation field?
Would you consider adjuvant radiation for a patient with recurrent pelvic node melanoma s/p immunotherapy and pelvic lymph node dissection with complete pathological response (only necrotic tissue; no viable melanoma)?